首页> 美国卫生研究院文献>International Journal of Clinical and Experimental Medicine >Complete response after chemotherapy and radiotherapy of a tonsillar histiocytic sarcoma with regional lymph node involvement: a case report and review of the literature
【2h】

Complete response after chemotherapy and radiotherapy of a tonsillar histiocytic sarcoma with regional lymph node involvement: a case report and review of the literature

机译:扁桃体组织细胞肉瘤伴局部淋巴结肿大的化学疗法和放射疗法后的完全反应:一例报告并文献复习

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We describe a case of tonsillar histiocytic sarcoma (HS) with regional lymph node involvement and complete response after multi-disciplinary therapy. Immunohistochemistry showed strong positive tumor staining for CD 68, and negative staining for CD20, CD45R0 and CD30 and non-cohesive proliferation of neoplastic histiocytes. Systemic chemotherapy with cyclophosphamide, doxorubicin, vincristine, prednisone, and etoposide (CHOP-E) chemotherapy followed by radiotherapy was delivered to the patient. No evidence of recurrent disease existed on regular follow up three years later. The diagnostic methods and the practical treatment solutions are discussed here. We believe that although HS has been regarded as a potentially fatal disease entity, there remain some cases that do not pursue such an aggressive clinical course.
机译:我们描述了一例扁桃体组织细胞肉瘤(HS)与区域淋巴结受累,多学科治疗后完全反应。免疫组织化学显示,CD 68呈强阳性肿瘤染色,CD20,CD45R0和CD30呈阴性染色,且肿瘤组织细胞无黏附增生。患者先进行了环磷酰胺,阿霉素,长春新碱,泼尼松和依托泊苷(CHOP-E)化疗的全身化学疗法,然后进行放射治疗。三年后的定期随访中没有复发疾病的证据。本文讨论了诊断方法和实际治疗方案。我们认为,尽管HS被认为是潜在的致命疾病,但仍有一些病例并未采用如此积极的临床方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号